Don't forget your original intention and move forward courageously -- and Loqi 2019 Mid-Year Summary and Commendation Conference

LQ036, the world's first inhaled nano-antibody drug for the treatment of moderate and severe asthma, has completed the administration of the first patient in China's clinical phase I!

Novamab won the winner of the 2018 "Entrepreneurship in Shanghai" International Innovation and Entrepreneurship Competition